Reply to Bonten and Mevius

Benjamin Lazarus(University of Vienna), Benjamin A. Rogers(Monash University), David L. Paterson(The University of Queensland), Joanne L. Mollinger(Department of Agriculture, Fisheries and Forestry)

Clinical Infectious Diseases

April 24, 2015

10.1093/cid/civ276

Cited by 0

Related Papers

Antimicrobial Resistance in ESKAPE Pathogens

|Clinical Microbiology Reviews|2020|2k

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance

|JAMA|2018|779

Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease

|JAMA Internal Medicine|2016|725

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

|The Lancet Infectious Diseases|2017|521

Analysis of Antibiotic Resistance Genes in Multidrug-Resistant <i>Acinetobacter</i> sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center

|Antimicrobial Agents and Chemotherapy|2006|481